This assignment delves into the intricacies of testing anti-cancerous drugs, highlighting the importance of a comprehensive approach that incorporates multiple techniques. Cell culture models, genetically modified mice, and computational methods are discussed as essential tools for assessing drug efficacy and potential side effects. The document emphasizes the need for a holistic approach to cancer drug development, considering the complex interactions between tumor cells and their micro-environment.